Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension

[1]  M. Goumans,et al.  The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease Progression , 2021, Cells.

[2]  R. Rafikov,et al.  Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development , 2019, Antioxidants & redox signaling.

[3]  M. Cascante,et al.  Metabolic Alterations in Cardiopulmonary Vascular Dysfunction , 2019, Front. Mol. Biosci..

[4]  Paul G. Williams,et al.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.

[5]  I. Yoshino,et al.  Endothelial cells from pulmonary endarterectomy specimens possess a high angiogenic potential and express high levels of hepatocyte growth factor , 2018, BMC Pulmonary Medicine.

[6]  C. Martinez,et al.  Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England , 2018, Pulmonary circulation.

[7]  E. Tolosa,et al.  Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2G2019S-Parkinson’s disease , 2018, Journal of Translational Medicine.

[8]  Patty J. Lee,et al.  Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[9]  P. Carmeliet,et al.  Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism , 2017, Open Biology.

[10]  Takaharu Nakayoshi,et al.  Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension , 2017, International journal of cardiology. Heart & vasculature.

[11]  Poyu Chen,et al.  Comparison between xCELLigence biosensor technology and conventional cell culture system for real-time monitoring human tenocytes proliferation and drugs cytotoxicity screening , 2017, Journal of Orthopaedic Surgery and Research.

[12]  Roger D Kamm,et al.  On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics , 2017, Nature Protocols.

[13]  E. Fadel,et al.  Abnormal pulmonary endothelial cells may underlie the enigmatic pathogenesis of chronic thromboembolic pulmonary hypertension. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  U. Förstermann,et al.  Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis , 2017, Circulation research.

[15]  J. Barberà,et al.  Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry , 2016, Circulation.

[16]  M. Mcgoon,et al.  The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress , 2015, European Respiratory Journal.

[17]  M. Falasca,et al.  CD31 signals confer immune privilege to the vascular endothelium , 2015, Proceedings of the National Academy of Sciences.

[18]  E. Verbeken,et al.  Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension , 2015, European Respiratory Journal.

[19]  P. Willems,et al.  Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism , 2015, Archives of Toxicology.

[20]  M. Goumans,et al.  Cardiac endothelial cells express Wilms' tumor-1: Wt1 expression in the developing, adult and infarcted heart. , 2015, Journal of molecular and cellular cardiology.

[21]  S. Archer,et al.  Mitochondrial dynamics in pulmonary arterial hypertension , 2015, Journal of Molecular Medicine.

[22]  S. Ulrich,et al.  Chronic thromboembolic pulmonary hypertension. , 2014, Swiss medical weekly.

[23]  W. Klepetko,et al.  Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients , 2014, European Respiratory Journal.

[24]  E. Wagner,et al.  Defective Angiogenesis Delays Thrombus Resolution: A Potential Pathogenetic Mechanism Underlying Chronic Thromboembolic Pulmonary Hypertension , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Skepper,et al.  Transcript Analysis Reveals a Specific HOX Signature Associated with Positional Identity of Human Endothelial Cells , 2014, PloS one.

[26]  J. Madri,et al.  CD44 Regulation of Endothelial Cell Proliferation and Apoptosis via Modulation of CD31 and VE-cadherin Expression* , 2014, The Journal of Biological Chemistry.

[27]  B. Meyns,et al.  NF-κB pathway is involved in CRP-induced effects on pulmonary arterial endothelial cells in chronic thromboembolic pulmonary hypertension. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[28]  Sara Cipolat,et al.  Mitochondrial Cristae Shape Determines Respiratory Chain Supercomplexes Assembly and Respiratory Efficiency , 2013, Cell.

[29]  Chen Wang,et al.  Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. , 2013, The New England journal of medicine.

[30]  D. Newby,et al.  Late Outgrowth Endothelial Cells Resemble Mature Endothelial Cells and Are Not Derived from Bone Marrow , 2013, Stem cells.

[31]  S. Sakao,et al.  Crosstalk between endothelial cell and thrombus in chronic thromboembolic pulmonary hypertension: perspective. , 2013, Histology and histopathology.

[32]  F. Wuytack,et al.  Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients , 2012, Respiratory Research.

[33]  Ernesto Alfaro-Moreno,et al.  Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension , 2012, European Respiratory Journal.

[34]  J. Barberà,et al.  Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry , 2011, Circulation.

[35]  W. Klepetko,et al.  Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. , 2011, The Journal of thoracic and cardiovascular surgery.

[36]  J. Mackey,et al.  Metabolic Modulation of Glioblastoma with Dichloroacetate , 2010, Science Translational Medicine.

[37]  T. Nawrot,et al.  C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.

[38]  Olga Tura,et al.  Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources , 2007, Journal of Translational Medicine.

[39]  K. Pollok,et al.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. , 2004, Blood.

[40]  P. Corris,et al.  Interventional and surgical modalities of treatment for pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[41]  A. Sapino,et al.  Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells. , 2003, The American journal of pathology.

[42]  Timothy R Billiar,et al.  Impaired wound healing and angiogenesis in eNOS-deficient mice. , 1999, American journal of physiology. Heart and circulatory physiology.

[43]  M. Rabinovitch,et al.  Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. , 1992, The American review of respiratory disease.

[44]  W. D. Smith,et al.  Perspective , 1974 .

[45]  N S Braunwald,et al.  Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension. , 1973, Chest.

[46]  A. Gautier,et al.  C-reactive protein , 2005 .

[47]  I. Blanco,et al.  Diagnóstico clínico y hemodinámico de la hipertensión pulmonar tromboembólica crónica , 2009 .

[48]  J. Barberà,et al.  [Clinical and hemodynamic diagnosis in chronic thromboembolic pulmonary hypertension]. , 2009, Archivos de bronconeumologia.

[49]  W. Auger,et al.  Chronic thromboembolic pulmonary hypertension. , 2009, Seminars in respiratory and critical care medicine.